pregnanc
classic
consid
risk
factor
develop
sever
influenza
diseas
although
data
relat
novel
influenza
viru
still
process
seem
infect
caus
novel
viru
sever
pregnant
women
nevertheless
infect
caus
influenza
viru
mild
present
specif
form
influenzalik
ill
ili
ili
syndrom
caus
divers
aetiolog
agent
specif
treatment
found
studi
evalu
aetiolog
ili
pregnant
women
aetiolog
ili
chang
time
region
among
differ
subpopul
gain
knowledg
epidemiolog
ili
might
help
manag
pregnant
women
infect
influenza
main
goal
studi
describ
clinic
characterist
prognosi
aetiolog
ili
pregnant
women
addit
sought
evalu
ili
caus
aetiolog
could
distinguish
clinic
standpoint
purpos
prospect
observ
studi
design
conduct
hospit
universitario
la
paz
madrid
spain
june
first
death
attribut
certifi
spain
patient
thirdterm
pregnant
women
sinc
given
uncertainti
risk
manag
pregnant
women
infect
pregnant
women
ili
present
hospit
universitario
la
paz
admit
hospitalis
diagnost
test
influenza
viru
specif
reversetranscriptas
polymeras
chain
reaction
rtpcr
nasopharyng
swab
perform
patient
recommend
use
neuraminidas
inhibitor
ni
chang
cours
studi
first
use
ni
individualis
per
clinic
judgment
august
specif
protocol
manag
ili
pregnanc
local
approv
fig
hospit
universitario
la
paz
tertiari
academ
centr
belong
spanish
nation
health
servic
provid
medic
assist
mix
urban
rural
popul
approxim
peopl
madrid
spain
time
frame
studi
includ
period
juli
septemb
studi
approv
institut
review
board
hospit
universitario
la
paz
ili
defin
fever
temperatur
greater
least
two
follow
cough
b
sore
throat
c
headach
rhinorrhoea
e
myalgia
f
short
breath
confirm
case
infect
defin
person
ili
laboratoryconfirm
infect
one
follow
test
realtim
rtpcr
viral
cultur
nasopharyng
swab
viral
perform
pregnant
women
admit
ili
extract
proceed
accord
manufactur
protocol
obtain
sampl
combin
ml
lysi
buffer
incub
room
temperatur
min
lysi
sampl
load
onto
easymag
system
durham
nc
realtim
rtpcr
assay
perform
use
center
diseas
control
prevent
cdc
protocol
rtpcr
microbiolog
test
perform
upon
clinician
request
real
time
aliquot
nasopharyng
swab
frozen
retrospect
process
respiratori
viru
panel
rvp
assay
pneumovir
kit
genomica
sau
zeltia
madrid
spain
follow
viru
type
subtyp
identifi
use
rvp
influenza
influenza
b
respiratori
syncyti
viru
subtyp
respiratori
syncyti
viru
subtyp
b
parainfluenza
parainfluenza
parainfluenza
parainfluenza
viru
human
metapneumoviru
rhinoviru
coronaviru
adenoviru
routin
microbiolog
test
process
local
microbiolog
laboratori
request
follow
variabl
describ
demograph
epidemiolog
data
age
ethnic
close
contact
patient
ili
clinic
data
highrisk
condit
influenza
infect
pregnanc
symptom
admiss
time
sinc
symptom
initi
first
medic
consult
antivir
antibiot
treatment
receiv
intens
care
unit
icu
admiss
microbiolog
diagnosi
laboratori
data
leucocyt
creactiv
protein
crp
creatin
phosphokinas
cpk
lactic
dehydrogenas
ldh
obstetr
gestat
age
diagnosi
gravid
pariti
prenat
care
complic
develop
ili
arithmet
mean
median
rang
determin
quantit
variabl
comparison
ili
caus
noninfluenzarel
ili
made
test
qualit
variabl
u
wilcoxon
wtest
quantit
variabl
valu
p
consid
statist
signific
fortyf
pregnant
women
ili
includ
fig
demograph
shown
tabl
total
women
confirm
infect
case
influenza
viru
differ
found
among
women
neg
test
infect
virus
five
rhinoviru
one
bocaviru
one
adenoviru
two
parainfluenza
one
parainfluenza
one
parainfluenza
viru
one
patient
coinfect
rhinoviru
patient
aetiolog
agent
identifi
one
patient
pregnant
woman
posit
rtpcr
microbiolog
workup
sever
atyp
respiratori
neg
patient
includ
studi
mainli
caucasian
condit
consid
increas
risk
complic
infect
found
studi
popul
follow
one
patient
type
diabet
mellitu
gestat
diabet
previous
diagnos
two
patient
two
patient
asthmat
one
patient
suffer
crohn
diseas
splenectomis
consequ
idiopath
thrombocytopen
purpura
distribut
trimest
present
tabl
deliveri
induc
low
foetal
reactiv
one
pregnant
woman
posit
rtpcr
two
deliveri
occur
ili
patient
one
induc
low
foetal
reactiv
instrument
vagin
deliveri
due
nonprogress
newborn
healthi
clinic
laboratori
featur
shown
tabl
fig
none
patient
die
readmit
due
worsen
symptom
two
week
follow
admiss
three
patient
ili
diagnos
patient
admit
one
patient
confirm
infect
admiss
due
preterm
deliveri
could
justifi
clinic
obstetr
criteria
total
three
chest
xray
made
upon
focal
clinic
find
lung
examin
crackl
wheez
normal
without
pulmonari
infiltr
notic
low
elev
acut
phase
reactant
group
six
women
confirm
infect
receiv
oseltamivir
mg
twice
daili
period
day
two
oseltamivir
prescrib
previous
approv
therapeut
protocol
infect
fig
one
two
patient
oseltamivir
prescrib
therapeut
protocol
approv
addit
risk
factor
sever
gestat
diabet
patient
receiv
oseltamivir
protocol
approv
due
clinic
suspicion
pneumonia
confirm
chest
xray
four
case
receiv
oseltamivir
approv
protocol
mean
time
onset
symptom
oseltamivir
administr
day
one
woman
receiv
oseltamivir
day
symptom
onset
advers
effect
relat
oseltamivir
therapi
studi
noninfluenzarel
ili
remain
undiagnos
aetiolog
standpoint
almost
half
pregnant
women
despit
use
rtpcr
microarray
focuss
preval
respiratori
virus
onethird
noninfluenzarel
ili
pregnant
women
altern
aetiolog
diagnosi
interestingli
frequent
found
agent
rhinoviru
follow
parainfluenza
viru
none
aetiolog
agent
specif
treatment
clinic
present
patient
infect
altern
agent
sever
respiratori
virus
clear
season
variat
aetiolog
ili
expect
time
region
though
remark
studi
perform
spain
summertim
inde
fact
could
explain
absenc
respiratori
syncyti
viru
addit
impact
epidemiolog
circul
respiratori
viru
remain
unknown
consid
although
sampl
size
small
seen
even
trend
suggest
infect
clinic
distinguish
ili
caus
infect
fact
hamper
proper
identif
pregnant
women
influenza
would
benefit
earli
antivir
therapi
postul
one
relev
modifi
factor
influenc
sever
diseas
pregnant
women
inde
signific
clinic
problem
viru
start
circul
time
enough
inform
sever
diseas
enough
data
safeti
neuraminidas
inhibitor
pregnanc
yet
avail
addit
lack
inform
time
circul
significantli
epidem
threshold
madrid
case
per
inhabit
one
three
ili
due
influenza
standpoint
decid
empir
treat
antivir
epidemiolog
context
sever
clinic
present
presenc
addit
risk
factor
sever
diseas
consid
given
low
sensit
rapid
antigen
test
report
studi
period
decid
includ
assay
diagnost
protocol
nevertheless
due
high
posit
predict
valu
posit
result
could
help
promptli
identifi
pregnant
women
infect
influenza
regardless
necess
perform
rtpcr
studi
sever
drawback
first
limit
sampl
size
anoth
limit
microbiolog
workup
mainli
focuss
viru
bacteri
pathogen
especi
atyp
bacteria
mycoplasma
pneumonia
could
respons
ili
pregnant
women
summertim
conclud
found
geograph
area
studi
period
aetiolog
ili
pregnanc
could
predict
base
clinic
laboratori
characterist
clinic
cours
ili
mild
regardless
aetiolog
would
like
remark
beyond
content
phase
influenza
pandem
alert
plan
clinic
decis
protocol
pregnant
women
ili
adjust
local
epidemiolog
context
close
monitor
basi
nonspecif
present
influenza
pregnant
women
standpoint
especi
necessari
pandem
influenza
activ
remain
epidem
threshold
circumst
perhap
individualis
manag
protocol
recommend
addit
basi
result
believ
applic
extens
microbiolog
workup
nonsever
ill
ili
pregnant
women
effici
provid
great
assist
manag
patient
